{"transactions":[{"id":724096,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-29T23:05:21.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":29888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":29888,"derivative":{"exercise_price":16.01,"exercise_date":"2027-06-26","expiration_date":"2036-06-26","underlying":"Common Stock","underlying_shares":29888},"source":{"system":"sec-edgar","filing":"0001193125-26-288906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526288906/ownership.xml","form_type":"4"}},{"id":945709,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:41:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":35500,"derivative":{"underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001586894-26-000002","document":"form4-01062026_090111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689426000002/form4-01062026_090111.xml","form_type":"4"}},{"id":945708,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:41:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":214000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":214000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":214000},"source":{"system":"sec-edgar","filing":"0001586894-26-000002","document":"form4-01062026_090111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689426000002/form4-01062026_090111.xml","form_type":"4"}},{"id":951698,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T14:00:06.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":19532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date."}],"balance_after":19532,"derivative":{"exercise_price":3.72,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":19532},"source":{"system":"sec-edgar","filing":"0001193125-26-001609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526001609/ownership.xml","form_type":"4"}},{"id":964389,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964388,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964387,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964386,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":10720,"price":9.0605,"value":97128.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0449 to $9.1451 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68149,"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964385,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":29333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,771 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":78869,"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":1101088,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-26T20:25:22.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":1.45,"exercise_date":"2026-06-24","expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000950170-25-090420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000095017025090420/ownership.xml","form_type":"4"}},{"id":1125151,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2025-06-03T20:15:11.000Z","date":"2025-05-23","kind":"gift","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Multani Family Trust U/A  DTD 08/10/2006"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The Reporting Person transferred 6,200 shares of common stock to a family trust for no consideration, for estate planning purposes.  The Reporting Person holds all voting and dispositive power with respect to the securities held by the trust and remains the beneficial owner of such securities."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0000950170-25-080941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000095017025080941/ownership.xml","form_type":"4"}},{"id":1125150,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2025-06-03T20:15:11.000Z","date":"2025-05-23","kind":"gift","planned":false,"acquired":false,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The Reporting Person transferred 6,200 shares of common stock to a family trust for no consideration, for estate planning purposes.  The Reporting Person holds all voting and dispositive power with respect to the securities held by the trust and remains the beneficial owner of such securities."}],"balance_after":166666,"source":{"system":"sec-edgar","filing":"0000950170-25-080941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000095017025080941/ownership.xml","form_type":"4"}},{"id":1168669,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":0.89,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1168668,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1168667,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1168666,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":7.84,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1168665,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":2.85,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1168664,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:15:11.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.73,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-25-011078","document":"form4-04212025_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011078/form4-04212025_080407.xml","form_type":"4"}},{"id":1313486,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:42:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-000602","document":"form4-01032025_100144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588925000602/form4-01032025_100144.xml","form_type":"4"}},{"id":1313485,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:42:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":202500,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001415889-25-000602","document":"form4-01032025_100144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588925000602/form4-01032025_100144.xml","form_type":"4"}},{"id":1328085,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328084,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328083,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328082,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":8850,"price":8.2817,"value":73293.045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 8,850 shares sold in the price range of $8.27 to $8.41 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":46765,"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328081,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":true,"shares":24042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":55615,"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1472128,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T12:39:48.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 20, 2025, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.03,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-24-005919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919124005919/doc4.xml","form_type":"4"}},{"id":1472362,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T11:16:45.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2024 annual stockholder meeting."}],"balance_after":60000,"derivative":{"exercise_price":0.89,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-017773","document":"form4-06212024_030641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588924017773/form4-06212024_030641.xml","form_type":"4"}},{"id":1690920,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:20:48.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-000368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919124000368/doc4.xml","form_type":"4"}},{"id":1690919,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:20:48.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":180000,"derivative":{"exercise_price":9.14,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-24-000368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919124000368/doc4.xml","form_type":"4"}},{"id":1692793,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T14:00:13.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":32867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments beginning one month from the date of grant, subject to such person's continuing in service on the board through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the election of the filing person, the option grant was issued in lieu of direct cash compensation payable to such person in 2024 in connection with each position on the board and its committees for which such person is anticipated to serve in 2024."}],"balance_after":32867,"derivative":{"exercise_price":2.13,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":32867},"source":{"system":"sec-edgar","filing":"0001209191-24-000271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919124000271/doc4.xml","form_type":"4"}},{"id":1704365,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:42:03.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-23-059266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123059266/doc4.xml","form_type":"4"}},{"id":1704364,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:42:03.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":6042,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001209191-23-059266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123059266/doc4.xml","form_type":"4"}},{"id":1704363,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:42:03.000Z","date":"2023-12-15","kind":"sale","planned":false,"acquired":false,"shares":5282,"price":8.5859,"value":45350.7238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 5,282 shares sold in the price range of $8.57 to $8.795 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":23809,"source":{"system":"sec-edgar","filing":"0001209191-23-059266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123059266/doc4.xml","form_type":"4"}},{"id":1704362,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:42:03.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":14042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":29091,"source":{"system":"sec-edgar","filing":"0001209191-23-059266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123059266/doc4.xml","form_type":"4"}},{"id":1844264,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T13:14:00.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 22, 2024, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.66,"exercise_date":"2024-06-22","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-039588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919123039588/doc4.xml","form_type":"4"}},{"id":1859284,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T16:31:46.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2024 annual stockholder meeting."}],"balance_after":60000,"derivative":{"exercise_price":1.39,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-036334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919123036334/doc4.xml","form_type":"4"}},{"id":2006563,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-17T21:25:07.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":2227,"price":3.0739,"value":6845.5753,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."}],"balance_after":7285,"source":{"system":"sec-edgar","filing":"0001209191-23-010616","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123010616/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-16"}},{"id":2035192,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-02T21:13:32.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":24000,"derivative":{"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-23-006198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123006198/doc4.xml","form_type":"4"}},{"id":2035191,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T21:13:32.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":145000,"derivative":{"exercise_price":6,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001209191-23-006198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919123006198/doc4.xml","form_type":"4"}},{"id":2083293,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-17T01:51:05.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":12084,"derivative":{"underlying":"Common Stock","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001209191-22-061756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122061756/doc4.xml","form_type":"4"}},{"id":2083292,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-17T01:51:05.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":2089,"price":3.25,"value":6789.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."}],"balance_after":7423,"source":{"system":"sec-edgar","filing":"0001209191-22-061756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122061756/doc4.xml","form_type":"4"}},{"id":2083291,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-17T01:51:05.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,471 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":9512,"source":{"system":"sec-edgar","filing":"0001209191-22-061756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122061756/doc4.xml","form_type":"4"}},{"id":2203745,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":108750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":108750,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2203744,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":90000,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2203743,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":147500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3rd) of the shares subject to the option shall vest on July 20, 2023, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":147500,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":147500},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2203742,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":108750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty five percent (25%) of the shares subject to the option would have vested on February 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option would have vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2203741,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty five percent (25%) of the shares subject to the option vested on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2203740,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:08:29.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":147500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the option vested on April 23, 2021, and one forty-eighth (1/48th) of the shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":147500},"source":{"system":"sec-edgar","filing":"0001209191-22-042843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122042843/doc4.xml","form_type":"4"}},{"id":2222127,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T13:18:18.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 22, 2023, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.35,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-039105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919122039105/doc4.xml","form_type":"4"}},{"id":2222267,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T11:13:07.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2023 annual stockholder meeting."}],"balance_after":50000,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-039120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919122039120/doc4.xml","form_type":"4"}},{"id":2415835,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-02T21:09:02.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":18125,"derivative":{"underlying":"Common Stock","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001209191-22-006339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122006339/doc4.xml","form_type":"4"}},{"id":2415834,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T21:09:02.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":108750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2023, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":108750,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":108750},"source":{"system":"sec-edgar","filing":"0001209191-22-006339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919122006339/doc4.xml","form_type":"4"}},{"id":2629306,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T00:46:10.000Z","date":"2021-07-20","kind":"purchase","acquired":true,"shares":6200,"price":16,"value":99200.0,"ownership":{"direct":true},"balance_after":172866,"source":{"system":"sec-edgar","filing":"0000899243-21-029060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000089924321029060/doc4.xml","form_type":"4"}},{"id":2655072,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:29:59.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2022 annual stockholder meeting."}],"balance_after":35000,"derivative":{"exercise_price":7.84,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-043353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919121043353/doc4.xml","form_type":"4"}},{"id":2884652,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T00:31:21.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2022, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":90000,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-006963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919121006963/doc4.xml","form_type":"4"}},{"id":3110821,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T12:39:16.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2020 annual stockholder meeting."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-036522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919120036522/doc4.xml","form_type":"4"}},{"id":3168958,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-27T20:43:23.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":147500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter."}],"balance_after":147500,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":147500},"source":{"system":"sec-edgar","filing":"0001209191-20-025810","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000120919120025810/doc4.xml","form_type":"4"}},{"id":3249804,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-25T17:42:20.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares vest on February 21, 2021 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter, such that the option will be fully vested on the fourth (4) anniversary of the date of grant, subject to Optionholder's Continuous Service as of each such date."}],"balance_after":60000,"derivative":{"exercise_price":1.73,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-012650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000120919120012650/doc4.xml","form_type":"4"}},{"id":4065565,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T15:34:55.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-009150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919118009150/doc4.xml","form_type":"4"}},{"id":4065564,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T15:34:55.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6.9,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-009150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919118009150/doc4.xml","form_type":"4"}},{"id":4065563,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-12T15:34:55.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":74134,"price":27,"value":2001618.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the acquisition of the Issuer by Roche Holdings, Inc. (\"Parent\") on February 8, 2018, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Abingdon Acquisition Corp. (\"Merger Sub\") dated December 21, 2017, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the \"Shares\") for a purchase price of $27.00 per Share (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-009150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919118009150/doc4.xml","form_type":"4"}},{"id":4105062,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-05T20:10:41.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest as to 25% of the shares underlying each award on each anniversary of the Grant Date, subject to the Reporting Person's continues service with the Company through the vesting date."}],"balance_after":74134,"source":{"system":"sec-edgar","filing":"0001209191-18-002594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919118002594/doc4.xml","form_type":"4"}},{"id":4122203,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-22T21:49:26.000Z","date":"2017-12-22","kind":"grant","acquired":true,"shares":23334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest as to 25% of the shares underlying each award on each anniversary of the Grant Date, subject to the Reporting Person's continues service with the Company through the vesting date."}],"balance_after":69734,"source":{"system":"sec-edgar","filing":"0001209191-17-067164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919117067164/doc4.xml","form_type":"4"}},{"id":4495961,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T18:54:14.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests.  25% of the shares subject to the option vest on January 5, 2018, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":50000,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-002771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557421/000120919117002771/doc4.xml","form_type":"4"}}]}